Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T07:28:59.818Z Has data issue: false hasContentIssue false
  • English
  • Français

Measuring Quality of Life in Persons With Dementia

Published online by Cambridge University Press:  10 January 2005

Peter V. Rabins
Peter V. Rabins
Affiliation:
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Get access

Extract

The development of treatment outcome measures has followed a pattern in which treatments are first developed to affect symptoms, and measures are developed concomitantly to detect differences in response rates between the treatment group and a comparison placebo group. For example, in the 1950s, distinct pharmacologic therapies were developed to lower blood pressure and to lessen the hallucinations and delusions associated with schizophrenia. At the same time, measures to assess these latter outcomes were validated.

Type
Perspectives of BPSD
Information
International Psychogeriatrics , Volume 12 , Issue S1 , July 2000 , pp. 47 - 49
Copyright
© 2000 International Psychogeriatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)